module 16 DM overview Flashcards
insulin
glucose uptake into cells
produced in the B-cells of the pancreas
glucagon
hormone produced in a cells of pancreas, promotes breakdown of glycogen to glucose in liver.
inulin
regulates appetite, gastric emptying
Type 1
autoimmune destruction of B cells of the pancreas
- absolute insulin deficiency
Type 2
progressive loss of B cell insulin secretion
- variable degrees of insulin resistance, impaired insulin secretion, and inc. hepatic glucose production
drugs for DM: insulins
Rapid, short acting - lispro, regular Intermediate-acting - NPH, lente Slow, long-acting - glargine
drugs for DM: non-insulin
insulin secretagogues - glipizide biguanides - metformin alpha-glucosidase inhibitors - acarbose thiazolidinediones - pioglitazone amylin analogs - pramlintide incretin modulators - GLP1 analong: exenatide - DPP4 inhibitor: sitagliptin SGLT2 inhibitors - canagliflozin
insulin release stimuli
glucose
other sugars
hormones: GLP-1, glucagon
SNS: activation of B2 Rc
effects of insulin/MOA
stimulates entry of glucose into cells
inhibits gluconeogenesis
inc. fat storage and prevents fat use for energy
stimulates amino acid uptake and protein synthesis
Insulin use
T1DM
T2DM
formulations of insulin
natural: regular
insulin analogues: modified
rapid acting insulin meds
lispro aspart glulisine humalog novolog apidra
rapid acting insulin onset-duration
onset: 15-30 min
peak: 0.5-2.5hr
duration: 3-5hr
rapid action insulin admin time
15 min. before meals
short acting meds
regular
humulin R
novolin R
short acting insulin onset-duration
onset: 30-60 min
peak: 2-3 hr
duration: 5-8 hr
short acting insulin admin times
30 min before meals
intermediate acting meds
isophane (NPH) regular U500 Humulin N novolin N humulin R: U500
NPH formulary
conjugated regular insulin with protamine
intermediate acting onset-duration
onset: 2-4 hr
peak: 4-10hr
duration: 10-16hr
intermediate acting admin time
30-60 min before meals
or bedtime
long acting insulin meds
glargine
lantus
detemir
levemire
glargine and lantus peak-duration
onset: 2-4 hr
peak: none
duration: 20-24hr
detmir and levemire onset-duration
onset: 3-4hr
peak: 6-8hr
duration: 6-23hr
glargine and lantus time admin
every 24 hr
detemir and levemire admin times
every 12-14 hrs
glargine formulary
dec. solubility at physiologic pH
- > release small amounts over time
detemir MOA
binds to albumin
ultra-long acting insulin med
degludec
degludec onset-duration
duration: at least 42 hours
degludec formulary
active at physiologic pH
-> depot form: slow, continuous absorption
insulin dosing
T1DM: 0.5 unit/kg/day
T2DM: 0.2-0.6 unit/kg/day
insulin AE
hypoglycemia
wt. gain
dec. K
lipodystrophy